ROYAL BANK OF CANADA - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$17,329,000
+84.1%
100,694
+34.2%
0.01%
+66.7%
Q2 2021$9,413,000
-8.0%
75,010
-0.6%
0.00%0.0%
Q1 2021$10,234,000
+3.6%
75,467
-2.3%
0.00%0.0%
Q4 2020$9,883,000
+25.4%
77,252
+10.3%
0.00%0.0%
Q3 2020$7,883,000
+91.0%
70,056
+61.7%
0.00%
+50.0%
Q2 2020$4,128,000
+5404.0%
43,335
+5102.3%
0.00%
Q1 2020$75,000
-50.3%
833
-70.7%
0.00%
Q4 2019$151,000
+4933.3%
2,847
+3172.4%
0.00%
Q3 2019$3,000
-62.5%
87
-55.6%
0.00%
Q2 2019$8,000
+33.3%
196
+63.3%
0.00%
Q1 2019$6,000
-14.3%
120
-23.6%
0.00%
Q4 2018$7,000
-87.7%
157
-84.3%
0.00%
Q3 2018$57,000
+338.5%
997
+282.0%
0.00%
Q2 2018$13,000
+550.0%
261
+715.6%
0.00%
Q1 2018$2,000
-85.7%
32
-89.9%
0.00%
Q4 2017$14,000
-87.8%
316
-89.7%
0.00%
Q3 2017$115,000
+3733.3%
3,079
+3359.6%
0.00%
Q2 2017$3,000
-88.5%
89
-91.0%
0.00%
Q1 2017$26,000
-36.6%
988
-38.7%
0.00%
Q4 2016$41,000
+1266.7%
1,611
+2106.8%
0.00%
Q3 2016$3,000
+50.0%
73
+40.4%
0.00%
Q2 2016$2,000
+100.0%
520.0%0.00%
Q1 2016$1,000
-50.0%
52
+57.6%
0.00%
Q4 2015$2,000
-92.3%
33
-96.8%
0.00%
Q3 2015$26,000
-40.9%
1,041
-26.0%
0.00%
Q2 2015$44,000
+780.0%
1,406
+1024.8%
0.00%
Q1 2015$5,000
-37.5%
125
-35.6%
0.00%
Q4 2014$8,0001940.00%
Other shareholders
ACCELERON PHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,449,300$59,537,000,0006.61%
Foresite Capital Management II, LLC 188,602$7,748,0004.36%
Foresite Capital Management III, LLC 254,923$10,472,0003.43%
Artal Group S.A. 1,500,000$61,620,0002.49%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,305,174$53,617,0001.93%
Asymmetry Capital Management, L.P. 82,473$3,388,0001.84%
QVT Financial LP 190,977$7,845,0001.66%
SECTORAL ASSET MANAGEMENT INC 269,396$11,067,0001.32%
Sofinnova Investments, Inc. 241,043$9,902,0000.91%
Novo Holdings A/S 119,708$4,918,0000.69%
View complete list of ACCELERON PHARMA INC shareholders